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Abstract 22 
Dietary nitrate supplementation has positive effects on mitochondrial and muscle contractile 23 
efficiency during large muscle mass exercise in humans, and on skeletal muscle blood flow (Q̇) 24 
in rats. However, concurrent measurement of these effects has not been performed in humans. 25 
Therefore, we assessed the influence of nitrate supplementation on Q̇ and muscle oxygenation 26 
characteristics during moderate (40%peak) and severe (85%peak) intensity handgrip exercise in 27 
a randomized, double-blind, crossover-design. Nine healthy men (age: 25±2 yrs) completed four 28 
constant-power exercise tests (two per intensity) randomly assigned to condition (nitrate-rich 29 
(Nitrate) or nitrate-poor (Placebo) beetroot supplementation) and intensity (40%peak or 30 
85%peak). Resting mean arterial pressure was lower after Nitrate compared to Placebo (84±4 vs 31 
89±4 mmHg; p<0.01). All subjects were able to sustain 10 min of exercise at 40%peak in both 32 
conditions. Nitrate had no effect on exercise tolerance during 85%peak (Nitrate: 358±29, 33 
Placebo: 341±34 s; p=0.3). Brachial artery Q̇ was not different after Nitrate at rest or any time 34 
during exercise. Deoxygenated-[hemoglobin+myoglobin] was not different for 40%peak 35 
(p>0.05), but was elevated throughout 85%peak (p<0.05) after Nitrate. The metabolic cost (V̇O2) 36 
was not different at end exercise, however, the V̇O2 primary amplitude at the onset of exercise 37 
was elevated after Nitrate for the 85%peak work rate (96±20 vs 72±12 ml/min; p<0.05) and had 38 
a faster response. These findings suggest that an acute dose of Nitrate reduces resting blood 39 
pressure and speeds V̇O2 kinetics in young adults, but does not augment Q̇ or reduce steady-state 40 
V̇O2 during small muscle mass handgrip exercise. 41 
Keywords: Beetroot juice, NIRS, Kinetics, Dynamic exercise  42 
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New and Noteworthy 43 
 We show that acute dietary nitrate supplementation via beetroot juice increases the 44 
amplitude and speed of local muscle V̇O2 on-kinetics parameters during severe- but not 45 
moderate-intensity handgrip exercise. These changes were found in the absence of an increased 46 
blood flow response, suggesting the increased V̇O2 was attained via improvements in fractional 47 
O2 extraction and/or spatial distribution of blood flow within the exercising muscle. 48 
 49 
Introduction 50 
 Dietary nitrate supplementation is well documented to have positive effects during large 51 
muscle mass exercise in humans (4, 33, 38, 48, 50). These effects include lowering oxygen 52 
consumption (V̇O2) (4, 32, 38, 42), speeding V̇O2 kinetics (3, 6, 31, 32) and reducing the ATP 53 
cost of work (2, 26) during submaximal exercise, which may translate to the enhanced exercise 54 
tolerance found during severe intensity exercise (6, 31, 37, 50). The precise mechanism(s) for 55 
these effects still remains uncertain, but they are facilitated through the reduction of the dietary 56 
nitrate to nitrite by commensal bacteria in the mouth (40). Once absorbed into the circulatory 57 
system, nitrite
 
is readily converted to nitric oxide (NO) in hypoxic (16, 47) and acidic (41) 58 
environments, which are expected to be present at the exercising muscle. 59 
 Nitric oxide is a potent vasodilator (20, 22, 45); as such it had been proposed that nitrate
 
60 
supplementation may augment blood flow (Q̇) to active muscle. This was first experimentally 61 
investigated in rats during submaximal treadmill running (23, 24). These authors found that 62 
nitrate supplementation resulted in an increased Q̇ to the hindlimb, particularly to muscles 63 
composed of greater percentages of type II fibers. These findings demonstrate that nitrate
 
may 64 
change the regulation of Q̇ relative to V̇̇O2, as these two variables generally increase in 65 
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proportion to one another across a range of exercise intensities (1, 43). Recently the effect of 66 
nitrate
 
on Q̇ was investigated in human subjects (5, 12, 34), but no change in brachial artery 67 
blood flow (Q̇BA) was found in healthy, young men and women during light-to-moderate 68 
intensity handgrip exercise. These previous studies might not have recruited type II fibers in the 69 
younger subjects due to lower intensity exercise, potentially missing the preferential effects of 70 
dietary nitrate on higher order fiber types (for review see (30)). It should be noted, two of the 71 
aforementioned studies did find improvements in compromised populations (i.e., older adults in 72 
hypoxia (12) and ‘noncompensators’ (5)). 73 
Importantly, these previous studies in humans using nitrate
 
(12, 34), provided no measure 74 
of V̇O2or fractional O2 extraction (which can be estimated noninvasively via deoxygenated-75 
[hemoglobin + myoglobin] (deoxy-[Hb + Mb]) and used to estimate V̇O2) (7, 18, 19, 35). 76 
Moreover, the measurements were made after fixed durations of moderate intensity submaximal 77 
exercise and during the steady state, leaving the effects of nitrate
 
on local muscle V̇O2 during the 78 
exercise onset transient unknown. Since faster V̇O2 kinetics are associated with a reduction in the 79 
O2 deficit (and thus accumulation of fatigue inducing metabolites), these findings carry important 80 
implications for patient populations, such as chronic heart failure (CHF), as accumulating 81 
evidence suggests nitrate supplementation may be effective for enhancing quality of life through 82 
improvements in exercise and/or daily activity tolerance (21, 25, 51).  83 
Therefore, the purpose of this investigation was to resolve whether acute supplementation 84 
of nitrate preferentially provided positive effects in small muscle mass exercise during severe 85 
intensity exercise, where type II fibers would be recruited and greater hypoxic and acidic muscle 86 
environment exists. Specifically, we tested the hypotheses that with nitrate supplementation 87 
compared to placebo: 1) Q̇BA would be significantly elevated during severe, but not moderate 88 
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intensity exercise; 2) V̇O2 would be elevated during severe intensity exercise and display faster 89 
kinetics; and 3) tolerance of exercise (Tlim) would be increased during severe intensity exercise. 90 
 91 
Materials and Methods 92 
 Ten healthy, recreationally active men volunteered for the investigation (mean ± SD: age: 93 
25 ± 2 yrs; height: 178 ± 4 cm; body mass: 80 ± 10 kg; BMI: 25 ± 3 kg/m
2
). All experimental 94 
procedures in the present study were approved by the Institutional Review Board at Kansas State 95 
University and conformed to the standards set forth by the Declaration of Helsinki. Prior to 96 
participation in the study, all subjects were informed of the protocol, any possible health risks, as 97 
well as the probable benefits of the study. All subjects provided written informed consent to 98 
participate and completed a medical health history questionnaire to ensure absence of any known 99 
cardiovascular or metabolic diseases which would preclude them from the study.  100 
 101 
Experimental Protocol 102 
 All testing sessions were performed on a custom-built, two-handed handgrip ergometer 103 
previously described by our laboratory (7, 8). Briefly, the subjects were seated in an upright 104 
position at arm’s length from the ergometer with the hands pronated at heart level and directly in 105 
front of their torso. All sessions were performed utilizing a 50% duty-cycle (1.5 s contraction, 106 
1.5 s relaxation) and fixed 4 cm linear displacement that was maintained via audio cues. All 107 
subjects were familiarized with the exercise, audio cues, and duty-cycle prior to the first testing 108 
session. During the first visit, subjects performed an incremental test for the determination of 109 
peak power (Ppeak) starting at 1 Watt (W) and increasing at a rate of 0.5 W·min
-1
. The test was 110 
performed until volitional exhaustion or after three consecutive contraction cycles in which the 111 
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subject was unable to maintain the correct tempo or complete full contractions. Ppeak was 112 
recorded as the highest power obtained in which the subjects completed at least 30 s of the stage.  113 
The four subsequent visits were randomly assigned to 40 or 85 %Ppeak (two tests per 114 
intensity) and supplemental condition (see Supplementation below; Figure 1). The four constant 115 
power tests were performed for 10 min or until exhaustion for 40 and 85 %Ppeak, respectively. 116 
The coefficient of variation for tolerance of exercise (Tlim) at 85 %Ppeak intensity in our 117 
laboratory is ~7% (8). All testing sessions were separated by 48 - 72 h and subjects were asked 118 
to abstain from vigorous activity, food, and caffeine prior to testing for 12, 3, and 2 h, 119 
respectively. Upon arrival to the laboratory, the subjects sat quietly for 15 min, after which 120 
resting blood pressure measurements and subsequent plasma samples were obtained (See Figure 121 
1).  All exercise tests were performed at approximately the same time of day (± 1.5 h for each 122 
subject) between 1000 and 1500 hours. 123 
 124 
Supplementation 125 
 The exercise testing sessions were randomly assigned to nitrate or placebo beetroot 126 
supplementation conditions (one of each per intensity; i.e., nitrate + 40 %Ppeak and placebo + 40 127 
%Ppeak), creating a randomized, double-blind, crossover study design. In each condition, the 128 
subjects consumed beetroot concentrate (2 x 70 ml providing ~13 mmol nitrate) or nitrate-129 
depleted beetroot concentrate placebo (2 x 70 ml providing ~0.006 mmol nitrate; both Beet It 130 
Sport, James White Drinks, Ipswich, UK). Subjects consumed the shots on their own outside of 131 
the laboratory ~2.5 h before testing began to allow for maximal expression of plasma nitrite
 
132 
concentrations ([nitrite]) (49, 50) (See Figure 1). This dose of nitrate was chosen because it was 133 
shown to increase Tlim with no greater effects seen at higher doses (50). During the study, 134 
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subjects were asked to abstain from using mouthwash (29) and toothpaste or chewing gum that 135 
contained triclosan, as these products serve to reduce the oral bacteria needed to facilitate the 136 
conversion of nitrate to nitrite. Each exercise testing session was separated from the others by at 137 
least 48 h to allow plasma [nitrite] adequate time to return to pre-supplementation concentrations 138 
(50). Subjects were asked to maintain their normal diet with the exception of limiting foods high 139 
in nitrate, such as spinach and arugula (39). No subjects reported taking any multivitamins or 140 
anti-oxidant supplements. All subjects self-reported compliance with the supplemental protocol. 141 
No subjects reported gastrointestinal discomfort; however, when subjects reported typical 142 
symptoms (i.e., beeturia or red stools) they were assured this was a typical side effect of the 143 
nitrate supplementation. 144 
 145 
Measurements 146 
 Venous blood samples (5-6 ml) were separated into 1.5 ml Eppendorf tubes containing 5 147 
μl heparin (concentration 1000U/ml) and centrifuged at 3250 rpm at 4 °C for 5 min within 1 min 148 
of withdrawal. Plasma samples were then pipetted into separate Eppendorf tubes, flash frozen in 149 
liquid nitrogen, and stored at -80 °C until later analysis.  150 
 The measurements of plasma nitrate and nitrite were performed within 30 min of thawing 151 
via chemiluminescence with a NO analyzer (NOA 280i, Sievers Instruments, Boulder, CO, 152 
USA). In order to obtain plasma nitrite levels and to avoid potential reduction of nitrate, 153 
potassium iodide in acetic acid was used as a reductant. This reductant has the ability to reduce 154 
nitrite to NO but is incapable of reducing higher oxides of nitrogen (i.e., nitrate), thus increasing 155 
the specificity for nitrite. Plasma nitrate concentrations were obtained using the same apparatus 156 
with the stronger reductant vanadium chloride in hydrochloric acid at a temperature of 95 °C. 157 
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This stronger reductant reduces the sum of all nitrogen oxides with an oxidation state of +2 or 158 
higher, which is predominately nitrate (μM), but also includes both nitrite (nM) and nitrosothiols 159 
(nM). 160 
Resting blood pressure was measured in the left arm using an automated patient monitor 161 
(S/5 Light Monitor type F-LM1-03, Datex-Ohmeda General Electric, Finland) which makes use 162 
of the oscillometric technique. To increase accuracy, this machine utilizes a 3-lead ECG to 163 
monitor heart rate. This measurement was taken in triplicate and a mean value was obtained. 164 
Exercising blood pressure was taken from the left ankle using the same patient monitor while the 165 
subject was seated at the handgrip ergometer. During the measurement, subjects were asked to 166 
remain still and allow their leg to relax. A correction factor (pressure = measured pressure – 167 
(distance between the heart and ankle in meters x 76 mm Hg) was used to adjust for the 168 
increased hydrostatic pressure present between the ankle and heart (27). Pilot work performed in 169 
our lab validated the correction factor with measurements taken from the ankle and arm at heart 170 
level. This pilot work also revealed that the increase in blood pressure during 85 %Ppeak handgrip 171 
exercise exceeded the capabilities of the equipment to accurately measure ankle pressure so 172 
pressure was only obtained for the 40 %Ppeak intensity. 173 
The raw blood velocity profiles were measured in the right brachial artery using Doppler 174 
ultrasound (Vivid 3, GE Medical Systems, Milwaukee, WI, USA) operating in pulse wave mode 175 
at a Doppler frequency of 4.0 MHz with a phased linear array transducer probe operating at an 176 
imaging frequency of 6.7 MHz, and were stored for post-hoc analysis. For all testing sessions the 177 
Doppler gate was set to the full width of the brachial artery to ensure complete insonation and all 178 
Doppler velocity measurements were corrected for the angle of insonation, which was adjusted 179 
to be less than 60°. Measurements were made at least 3 cm above the antecubital fossa to avoid 180 
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bifurcation of the brachial artery. Brachial artery diameters were measured in the transverse axis 181 
using two-dimensional sonography. 182 
 Muscle and microvascular oxygenation status were measured noninvasively using a 183 
frequency-domain multi-distance near infrared spectroscopy (NIRS) system (OxiplexTS, ISS, 184 
Champaign, IL, USA) positioned over the belly of the left flexor digitorum superficialis (FDS). 185 
Details of this technique have been described previously (7, 11). Briefly, this device consists of 186 
one detector fiber bundle and eight light-emitting diodes (LED) operating at wavelengths of 690 187 
and 830 nm (four LEDs per wavelength). The LED-detector fiber bundle separation distances are 188 
2.0, 2.5, 3.0, and 3.5 cm. This NIRS device measures and incorporates the reduced scattering 189 
coefficient (μs′), measured dynamically, to provide absolute concentrations (μM) for deoxy-[Hb 190 
+ Mb] and total-[Hb + Mb]. The NIRS probe was calibrated prior to each test according to the 191 
manufacturer’s specifications. The belly of the FDS of the left arm was identified using palpation 192 
and EMG. The NIRS probe was secured along the belly of the FDS and was wrapped with an 193 
elastic bandage to prevent shifting of the probe. The placement of the NIRS probe was marked 194 
with permanent ink for reproducible positioning throughout the study. The NIRS data were 195 
collected at 50 Hz and stored for post-hoc analysis.  196 
The V̇O2 (ml O2·min
-1
) of the FDS was calculated for each minute of exercise using the 197 
technique described previously (7), which integrates deoxy-[Hb + Mb] and Q̇BA. It was assumed 198 
that the deoxy-[Hb + Mb] signal reflects exclusively deoxy-[Hb] [we acknowledge that the 199 
signal contains deoxy-[Mb] as well (17)] and that the entire signal arises only from the muscle 200 
(i.e., not from any interposing adipose or skin tissue).  With these assumptions the deoxy-[Hb] 201 
may be converted into an estimated V̇O2.  The deoxy-[Hb] values are in units of μmole heme/l 202 
tissue, where the tissue is assumed to be muscle.  These deoxy-[Hb] units can be converted into 203 
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μmole heme/l blood using the conversion 1.36% capillary blood volume/muscle volume [derived 204 
from 400 cap/mm
2, 28.3 μm2 CSA, and a coefficient of 1.2 correcting for tortuosity and 205 
branching of the capillaries (44)].  These units can then be converted into mole O2/l blood 206 
assuming 1 mole O2/mole heme and further to l O2/l blood using the conversion 22.4 l O2/mole 207 
O2.  V̇O2 values in l O2/min may then be obtained by multiplying this value by the measured Q̇BA 208 
values. This calculation was performed with the understanding that Q̇BA likely overestimates Q̇ 209 
through the capillaries under the NIRS probe. However, because the same calculation (and 210 
subsequent assumptions) was used across subjects and the primary comparison was within 211 
subjects, the error associated with this assumption was minimized. Further, these assumptions 212 
were held constant across both supplemental conditions. 213 
 214 
Data analysis 215 
Mean blood velocity (V̇mean; cm·s
-1
) was defined as the time-averaged mean velocity over 216 
each 3 s contraction cycle. Q̇BA (ml·min
-1
) was calculated using the product of V̇mean and vessel 217 
cross-sectional area (CSA = πr2). CSA (cm2) was calculated each minute of exercise using 218 
brachial artery diameters measured at the beginning of each minute. The Q̇BA data were analyzed 219 
using three consecutive contraction cycles (i.e., 9 s) for rest and at the end of each minute of 220 
exercise. The NIRS data were first multiplied by 4 to convert the values from hemoglobin 221 
equivalents back to total heme units (15) and were subsequently analyzed using 1 s mean values 222 
that were converted to 30 s mean bins for resting values and 9 s time-binned mean values at the 223 
end of each minute of exercise and at exhaustion. Systolic blood pressure (SBP) and diastolic 224 
blood pressure (DBP) were measured at least three times at rest and once every 2 min during 225 
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exercise and were then used to calculate MAP. Vascular conductance (VC) (ml·min
-1
·(100 226 
mmHg)
-1
) was calculated using the quotient of Q̇BA/MAP, multiplied by 100.  227 
Kinetics analyses were conducted for the V̇O2 data using 6 s time-binned mean values 228 
over the initial 120 s of exercise and 9 s time-binned mean values at 180 and 240 s with a mono-229 
exponential model:  230 
y(t) = y(b) + A(1 – e –(t – TD)/τ) 231 
where y(t) is the V̇O2 at any point in time, y(b) is the baseline before the onset of exercise, A is 232 
the primary amplitude of the response, TD is the time delay proceeding the increase in, and τ is 233 
the time constant. The rate constant (RC) was calculated as A divided by τ (giving ml/min/s) to 234 
give an indication of the acceleration of the response. 235 
 236 
Statistical analysis 237 
 All curve fitting and statistical analyses were performed using a commercially available 238 
software package (SigmaPlot 12.5, Systat Software, San Jose, CA, USA). Differences in resting 239 
values and Tlim were analyzed using Student’s paired t-tests. Differences within condition (i.e., 240 
40% nitrate and 85% nitrate) for resting plasma [NOx] and MAP were compared and if no 241 
differences were found, these values were averaged to represent the mean resting value for that 242 
condition. Exercising values (i.e., Q̇BA, deoxy-[Hb + Mb], total-[Hb + Mb], and V̇O2) were 243 
analyzed using two-way ANOVAs with repeated measures (supplement x time) using Tukey’s 244 
post hoc tests when main effects were detected. V̇O2 kinetics parameters were analyzed using 245 
two-way ANOVA with repeated measures (supplement x work rate) using Tukey’s post hoc tests 246 
when main effects were detected. Differences were considered significant when p < 0.05. Data 247 
are presented as means ± standard error unless otherwise noted.  248 
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 249 
Results 250 
 Ten subjects completed the protocol. One subject was determined to be an outlier based 251 
on their 85 %Ppeak Tlim change score (-285 s) being more than 3 SD outside the group mean 252 
change score (15 ± 84 s). This subject was removed from all data analyses. 253 
 254 
Plasma [nitrate] & [nitrite] and resting blood pressure 255 
 Plasma [nitrate] and [nitrite] was measured in six participants (see Limitations section 256 
below for explanation). Plasma [nitrate] was elevated 26-fold over placebo after acute nitrate 257 
supplementation (784 ± 32 vs 29 ± 2 μM, p < 0.001). All subjects demonstrated elevated plasma 258 
[nitrite] after acute nitrate supplementation (456 ± 60 vs 68 ± 7 nM, p < 0.001, Fig. 2) resulting 259 
in a 5.7-fold increase over placebo. Resting blood pressure values are presented in Table 1. 260 
Acute nitrate supplementation was associated with a lowering of SBP, DBP, and MAP by 7%, 261 
4%, and 6%, respectively (all p < 0.05) compared to placebo.  262 
 263 
40 %Ppeak exercise  264 
 The mean power for 40 %Ppeak was 2.2 ± 0.1 W. All subjects were able to sustain 10 min 265 
of exercise at 40 %Ppeak in both conditions. Q̇BA increased rapidly from exercise onset in both 266 
conditions before approaching a steady-state of approximately 260 ml·min
-1
 by 240 s. Q̇BA was 267 
not different after nitrate supplementation at rest or at any time during exercise compared to 268 
placebo (Fig. 3). MAP was measured during exercise in eight of nine subjects. There was no 269 
main effect of nitrate on MAP during exercise compared to placebo (p = 0.11, Fig. 4), although 270 
MAP was 4 mmHg lower on average throughout exercise before reaching the peak values 90 ± 4 271 
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and 98 ± 5 mmHg (p = 0.02) for nitrate and placebo, respectively. There was no effect of nitrate 272 
on VC (p = 0.14, Fig. 4); both groups increased to end exercise values of 314 ± 58 and 279 ± 28 273 
ml/min/100 mmHg (p = 0.08) for nitrate and placebo, respectively. 274 
 Deoxy-[Hb + Mb] increased following exercise onset in both conditions, with no 275 
differences between conditions. End exercise deoxy-[Hb + Mb] was not different between nitrate 276 
and placebo (154 ± 15 vs 156 ± 19 μM, p = 0.83, Fig. 5). Total-[Hb + Mb] was not different after 277 
nitrate supplementation at any min during exercise or at the end of exercise compared to placebo 278 
(408 ± 15 vs 402 ± 25 μM, p = 0.76, Fig. 5). V̇O2 was not different at any min during exercise or 279 
at the end of exercise (73.1 ± 16.7 vs 75.8 ± 18.0 ml/min, p = 0.68, Fig. 6). The results of the 280 
V̇O2 kinetics analysis are presented in Table 2 (n = 7).  281 
 282 
85 %Ppeak exercise 283 
 The mean power for 85 %Ppeak was 4.7 ± 0.2 W. Nitrate had no effect on Tlim compared 284 
to placebo (358 ± 29 vs 341 ± 34 s, p = 0.3, Fig. 7). Q̇BA was not different at rest or any time 285 
during exercise after nitrate supplementation. Q̇BA increased at exercise onset and attained end 286 
exercise values of 368 ± 42 and 353 ± 46 ml/min (p = 0.56, Fig. 3), for nitrate and placebo, 287 
respectively. 288 
 Deoxy-[Hb + Mb] was not different at rest and increased at exercise onset in both 289 
conditions, with nitrate elevated over placebo for time points preceding end exercise (60 – 180 s, 290 
p < 0.05), but not 240 s (p = 0.08). At Tlim, nitrate and placebo were different (203 ± 26 vs 180 ± 291 
19 μM, p = 0.03, Fig. 5). Total-[Hb + Mb] was not different after nitrate supplementation, both 292 
conditions showed a progressive increase toward the end exercise values (447 ± 30 vs 440 ± 31 293 
μM, p = 0.65). V̇O2 increased 897 ± 183% and 838 ± 191% (p = 0.83) from rest to Tlim for nitrate 294 
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and placebo, respectively. There was no difference for end exercise V̇O2 after nitrate 295 
supplementation (112 ± 12 vs 107 ± 14 ml/min, p = 0.62, Fig. 6). The results of the V̇O2 kinetics 296 
analysis are presented in Table 2 (n = 7). Both supplemental conditions had significantly higher 297 
primary amplitudes during 85% Ppeak compared to 40% Ppeak (p < 0.05). Nitrate supplementation 298 
also increased the primary amplitude within 85% Ppeak (p = 0.02) and reduced the time constant 299 
(τ; p = 0.04) compared to placebo.  300 
 301 
Discussion 302 
 The present study investigated the effects of acute nitrate supplementation on conduit 303 
artery Q̇ concurrently with local muscle microvascular oxygenation characteristics during 304 
moderate and severe intensity handgrip exercise. The acute dosage utilized (~13 mmol nitrate), 305 
elevated plasma [nitrite] more than 5-fold higher than that seen with placebo and was associated 306 
with reductions in blood pressure at rest of 4-8%. Contrary to our first hypothesis, nitrate had no 307 
effect on Q̇BA at rest or any time point during moderate or severe intensity handgrip exercise 308 
compared to placebo. The primary novel finding of the present study, in agreement with our 309 
second hypothesis, was that the V̇O2 primary amplitude was elevated and the kinetics were faster 310 
after nitrate during severe intensity handgrip exercise consequent to an increased O2 extraction 311 
(deoxy-[Hb + Mb]) . Additionally, nitrate had no effect on Tlim when exercise was performed in 312 
the severe intensity domain.  313 
 314 
Effect on control of blood flow 315 
 Ferguson and colleagues (23, 24) discovered that nitrate supplementation increased bulk 316 
hindlimb Q̇ in rats with the largest effect in muscles composed of a high percentage of type IIb 317 
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and IIx fibers (23, 24). To date, the previous studies (5, 12, 34) and the present investigation that 318 
directly measured Q̇ in young healthy humans during small muscle mass (handgrip) exercise, 319 
have been unable to replicate the findings of Ferguson et al. (23, 24) or Cosby et al. (14). The 320 
work of Kim and colleagues (34) had young healthy subjects perform rhythmic exercise under 321 
both nitrate and placebo conditions; however the work done was performed at fairly low work 322 
rates. The greatest Q̇BA achieved in the work of Kim et al. (34) was approximately 200 ml/min 323 
for both supplementations, which was lower than the Q̇BA measured in the present investigation 324 
at 40 %Ppeak (~260 ml/min). If dietary nitrate does in fact have preferential effects in high order 325 
fiber types, it is likely that Kim et al. (34) and the lower work rate in the present study did not 326 
recruit said fibers.  327 
 The other two studies (5, 12) and the present investigation performed higher intensity 328 
exercise that increased the likelihood of recruiting higher order fibers. However, in agreement 329 
with the lower intensity data, nitrate supplementation had no effect on the steady state Q̇BA in 330 
healthy young subjects. The present investigation advanced these previous studies by measuring 331 
the dynamic response during the onset of exercise. While there was no difference in the speed of 332 
the Q̇BA adjustment to exercise, there was evidence of improved O2 delivery within the 333 
exercising muscle (see Effect on tissue oxygenation and V̇O2 below). Casey and colleagues (12) 334 
attempted to maximize the stimulus for nitrite conversion to NO (and thus maximize the 335 
potential augmentation of Q̇BA) by putting their subjects in hypoxia, but there was still no 336 
difference between nitrate and placebo. The study by Bentley and colleagues (5) used a 337 
hydrostatic challenge to alter O2 delivery and found no differences in the absolute Q̇BA following 338 
nitrate supplementation. These authors did find there was less attenuation of Q̇BA induced by the 339 
hydrostatic challenge following nitrate, which the authors attributed to an increased 340 
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compensatory vasodilation (5). The supine exercise model used in these aforementioned studies 341 
(5, 12, 34) differed from the present investigation in that our subjects were seated upright with 342 
the arms at heart level. It has been shown that the seated posture increases muscle sympathetic 343 
activity and reduced central venous pressure compared to the supine posture (9). Since the 344 
present findings are largely in agreement with these previous studies (5, 12, 34) and handgrip 345 
exercise is not limited by cardiac output, these postural differences were likely inconsequential. 346 
 Nevertheless, a recent study found that acute nitrate supplementation increased peak 347 
cardiac output and V̇O2 in CHF patients with preserved ejection fraction during a supine peak 348 
incremental exercise test (51). This study was not designed to resolve the spatial distribution of 349 
the ~10% increase in cardiac output. If nitrate does favorably affect VC and Q̇ to type II fibers, 350 
as suggested by Ferguson and colleagues (24), the increased reliance on type II fibers with CHF, 351 
and other diseases (28, 46) supports the notion that nitrate supplementation may be more 352 
effective in these populations with O2 delivery challenges. The discovery that nitrate can increase 353 
Q̇BA in older adults in hypoxia (12) further bolsters this hypothesis. 354 
  355 
Effect on tissue oxygenation and V̇O2  356 
 Larsen and colleagues (38) were the first to show that a dietary nitrate salt supplement 357 
could reduce the V̇O2 associated with a given work rate. Subsequent studies utilizing beetroot 358 
supplementation have yielded mixed results across a variety of exercise modalities, with some 359 
showing ~3-5% reductions in V̇O2 (2, 4, 37, 42, 48, 50), and others no change (6, 13, 31, 32) 360 
after supplementation. NIRS-derived variables measured concurrently with V̇O2 paralleled the 361 
change in V̇O2 when it occurred (4, 6).  362 
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 Given the above, attempting to interpret the present findings in the context of whole body 363 
exercise is difficult. In the present investigation, deoxy-[Hb + Mb] was elevated after nitrate 364 
supplementation throughout severe-, but not moderate-, intensity exercise. Moreover, total-[Hb + 365 
Mb] was not impacted by nitrate supplementation during both exercise intensities. Changes in 366 
total-[Hb + Mb] from rest to exercise are thought to reflect the change in microvascular 367 
hematocrit (17). To the best of our knowledge, the current study is the first to observe an 368 
increased primary amplitude, exercising level, and Tlim value for deoxy-[Hb + Mb] after nitrate 369 
supplementation. It should be noted that Breese et al. (6) reported a higher value on beet root 370 
juice across the transition from moderate to severe exercise due to faster kinetics, but no 371 
differences in the amplitude or Tlim were observed (6). Increased deoxy-[Hb + Mb] relative to 372 
unchanged total-[Hb + Mb] (and Q̇BA), suggests an increased fractional O2 extraction. The 50% 373 
duty-cycle used in the present investigation has been shown to mechanically constrain Q̇BA and 374 
V̇O2 during severe intensity handgrip exercise (7), such that the present changes should be 375 
viewed as positive and suggest improvements in the microvascular distribution of O2 rather than 376 
a decrease in efficiency. Nitrate may facilitate the delivery of O2 to regions that were otherwise 377 
under perfused in this exercise model. This improved O2 extraction was manifest in the kinetic 378 
response (see discussion below); however, there was no difference in V̇O2 at the end of exercise 379 
after nitrate supplementation in the present investigation. This implies that the efficiency of the 380 
work was neither positively nor negatively impacted and the improvements in fractional O2 381 
extraction were likely obscured by the mechanical limitations of the exercise. Future work could 382 
usefully attempt to elucidate if there is a ‘threshold’ type effect of the duty cycle used for the 383 
exercise (i.e., employing 20, 30, 40% duty cycles in the severe intensity domain).  384 
 385 
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Effect on V̇O2 kinetics parameters and tolerance to exercise 386 
 No differences in the end exercise amplitude of local muscle V̇O2 were found in the 387 
present study, but kinetics analyses revealed that the initial amplitude of V̇O2 was increased 388 
during exercise at 85% Ppeak after nitrate supplementation. Nitrate supplementation resulted in a 389 
faster τ and a substantially greater rate constant (amplitude/τ; ~73% increase). These findings are 390 
in agreement with the speeding of pulmonary V̇O2 kinetics shown during whole body exercise in 391 
instances of compromised O2 delivery and/or recruitment of higher order Type II muscle fibers 392 
(3, 6, 31, 32) and the equivalent microvascular PO2 response in rats (23). The present 393 
investigation is the first to show significant differences in kinetics parameters after an acute 394 
dosage of nitrate, where other studies used chronic supplementation to see effects (3, 6, 31). 395 
However, these improvements in V̇O2 amplitude and speed of adjustment did not lead to 396 
improved Tlim in the present investigation. Previous work has found that speeding V̇O2 kinetics 397 
during whole body exercise does not always result in improvements to Tlim (10, 36), indicating 398 
that the relationship between these two variables is not a simple relationship. Indeed, interactions 399 
between V̇O2 kinetics and other physiological parameters are likely requisite to see 400 
improvements in exercise tolerance. Had there been a summation of the improved kinetics across 401 
multiple transitions (such as that seen during daily activity), a greater sparing of the O2 deficit 402 
could result in an accumulated improvement.  403 
 404 
Limitations 405 
 We acknowledge that the method used to estimate V̇O2 herein utilizes several 406 
assumptions (7) and likely overestimated the V̇O2. We contend that these assumptions, held 407 
constant throughout, should not obscure an impact of nitrate on V̇O2. Additionally, our sample 408 
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size was small and as such could have resulted in the present investigation not being sufficiently 409 
powered to detect differences in some variables (e.g., exercising MAP and VC). Finally, we did 410 
not measure plasma [nitrite] in all nine subjects (access to the NOA was precluded during later 411 
data collection); however, the three subjects without this measurement exhibited similar 412 
differences in blood pressure to the six with plasma [nitrite] measurements. It should be noted 413 
that no pre-dose blood pressure measurements were made in the present investigation.  However, 414 
each subject served as their own control and thus had two separate days of blood pressure 415 
measurements for each condition (i.e., nitrate and placebo), increasing our confidence that nitrate 416 
influenced blood pressure herein. 417 
 418 
Conclusions 419 
 The present study reaffirmed previous findings that an acute dose of nitrate is associated 420 
with lower SBP, DBP, and MAP in healthy, young men. The acute dose was also an effective 421 
method to increase and speed the local muscle V̇O2 on-kinetics parameters during severe 422 
intensity handgrip exercise, primarily through an increased fractional O2 extraction rather than 423 
increased blood flow. However, the ergogenic effects associated with nitrate supplementation 424 
(i.e., improved tolerance to exercise) during large muscle mass exercise were not seen when the 425 
exercise was performed in small muscle mass handgrip exercise. These findings warrant future 426 
studies investigating the effects of nitrate supplementation during the dynamic adjustment at the 427 
onset of exercise in populations at risk of O2 delivery impairment and reduced NO 428 
bioavailability.  429 
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Table 1. Resting Blood Pressure After Acute Dietary Nitrate Supplementation 
  Placebo Nitrate 
SBP (mmHg) 130 ± 4  121 ± 4 † 
DBP (mmHg)   69 ± 4    66 ± 5 * 
MAP (mmHg)   89 ± 4    84 ± 4 * 
SBP, DBP, and MAP denote systolic blood pressure, diastolic blood pressure, and mean arterial pressure, 
respectively. Values are expressed as means ± SE. † significantly different from placebo (p < 0.01),  * significantly 
different from placebo (p < 0.05) 
 605 
 606 
Table 2. V̇O2 Kinetics Parameters for the Onset of Handgrip Exercise 
40% Ppeak Placebo Nitrate 
Baseline (ml/min) 17 ± 3  16 ± 4 
Amplitude (ml/min)   52 ± 13  64 ± 8 
τ (s) 38 ± 5  34 ± 9 
TD (s)   1 ± 1    3 ± 1 
RC (ml/min/s)      1.6 ± 0.4    1.9 ± 0.6 
85% Ppeak   
Baseline (ml/min) 15 ± 4  17 ± 2 
Amplitude (ml/min)      72 ± 16 †        99 ± 22 *† 
τ (s) 37 ± 8    25 ± 3 * 
TD (s)   4 ± 2    6 ± 2 
RC (ml/min/s)      2.2 ± 0.4         3.8 ± 0.6 * 
τ, TD, and RC denote time constant, time delay, and rate constant, respectively. 
Values are expressed as means ± SE. * significantly different from placebo within 
work rate, † significantly different from 40% Ppeak within supplement (both p < 0.05). 
Analysis completed on 7 of 9 subjects. 
  607 
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Figure Legends 608 
Figure 1. Schematic representation of experimental protocol 609 
Left: overall protocol showing the timing of the five laboratory visits in relation to one another. 610 
Right: expansion of an individual testing day (in this case, Testing day #1; each subsequent 611 
testing session followed the same timeline). Each testing session was assigned randomly to the 612 
supplemental condition (i.e., nitrate or placebo) and exercise intensity (i.e., 40 or 85 %Ppeak). All 613 
exercise tests began approximately 2.5 h after supplement consumption. 614 
 615 
Figure 2. Resting nitrite concentrations 616 
Plasma nitrite concentration ([nitrite]) for individual subjects (gray lines) and group means (both, 617 
n = 6; see text for discussion of reduced subject number). Plasma nitrate concentrations were 618 
similar to [nitrite], these data are presented in text only. Error bars represent SE. * significantly 619 
different from placebo (p < 0.001). 620 
 621 
Figure 3. Brachial artery blood flow during exercise 622 
A: Mean brachial artery blood flow (Q̇BA) at the end of each minute of 40 %Ppeak exercise. B: 623 
Mean Q̇BA at the end of each minute of 85 %Ppeak exercise and the limit of exercise tolerance 624 
(Tlim). In both graphs, filled circles represent placebo and open circles represent nitrate 625 
supplementation (both, n = 9). Error bars represent SE. 626 
 627 
Figure 4. Mean blood pressure and vascular conductance responses to 40 %Ppeak exercise 628 
A: Mean arterial pressure (MAP) taken every 120 s during exercise. B: Vascular conductance 629 
(VC) calculated as the product of brachial artery blood flow and MAP every 120 s during 630 
exercise. In both graphs, filled circles represent placebo and open circles represent nitrate 631 
supplementation (both, n = 8). Error bars represent SE.  632 
 633 
Figure 5. NIRS-derived muscle and microvascular oxygenation responses during exercise 634 
Left: 40 %Ppeak exercise A: Mean deoxygenated-[hemoglobin + myoglobin] (deoxy-[Hb + 635 
Mb]) at the end of each minute of exercise. B: Mean total-[hemoglobin + myoglobin] (total-[Hb 636 
+ Mb]) at the end of each minute of exercise (both, n = 9). Right: 85 %Ppeak exercise C: Mean 637 
deoxy-[Hb + Mb] at the end of each minute of exercise and at the limit of exercise tolerance 638 
(Tlim). D: Mean total-[Hb + Mb] at the end of each minute of exercise and at Tlim. In all graphs, 639 
filled circles represent placebo and open circles represent nitrate supplementation (both, n = 9). 640 
Error bars represent SE. * significantly different from placebo (p < 0.05). 641 
 642 
Figure 6. Estimated V̇O2 during exercise 643 
A: Mean estimated V̇O2 at the end of each minute of 40 %Ppeak exercise. B: Mean estimated V̇O2 644 
at the end of each minute of 85 %Ppeak exercise and at the limit of exercise tolerance (Tlim). In 645 
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both graphs, filled circles represent placebo and open circles represent nitrate supplementation 646 
(both, n = 9). Error bars represent SE. 647 
 648 
Figure 7. Effect of supplementation on tolerance to exercise 649 
Individual (solid gray lines) and mean (n = 9) tolerance to exercise (Tlim) responses under both 650 
supplementations during 85 %Ppeak exercise. Error bars represent SE. 651 
 652 
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